Vital Signs - Taking Stock of the Next Generation of Medical Implant Technologies

Vital Signs - Taking Stock of the Next Generation of Medical Implant Technologies

 

RELEASE DATE
26-Jan-2011
REGION
North America
Research Code: 9561-00-B9-00-00
SKU: HC00614-NA-MR_04087
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00614-NA-MR_04087
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on January 26, 2011, provides a strategic overview of the next generation of medical implant technologies. Additionally, a company spotlight is provided for Ardian, Inc., a novel catheter-based treatment company for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, insulin resistance and heart failure. Reimbursement and regulatory news from the FDA is also provided for the week of January 3, 2011.

Table of Contents

This week's issue

Related Research
This issue of Vital Signs, released on January 26, 2011, provides a strategic overview of the next generation of medical implant technologies. Additionally, a company spotlight is provided for Ardian, Inc., a novel catheter-based treatment company for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, insulin resistance and heart failure. Reimbursement and regulatory news from the FDA is also provided for the week of January 3, 2011.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-B9-00-00
Is Prebook No